Your browser doesn't support javascript.
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
Meylan, Sylvain; Livio, Françoise; Foerster, Maryline; Genoud, Patrick James; Marguet, François; Wuerzner, Gregoire.
  • Meylan S; Department of Medicine, Infectious Diseases Service, University Hospital Lausanne and University of Lausanne, Switzerland (S.M.).
  • Livio F; Service of Clinical Pharmacology, Department of Laboratories (F.L.), Lausanne University Hospital and University of Lausanne, Switzerland.
  • Foerster M; Emergency Department (M.F.), University Hospital of Lausanne, Switzerland.
  • Genoud PJ; Nursing Directorate (P.J.G., F.M.), University Hospital of Lausanne, Switzerland.
  • Marguet F; Nursing Directorate (P.J.G., F.M.), University Hospital of Lausanne, Switzerland.
  • Wuerzner G; Department of Medicine, Service of Nephrology and Hypertension (G.W.), Lausanne University Hospital and University of Lausanne, Switzerland.
Hypertension ; 77(6): e56-e57, 2021 06.
Article in English | MEDLINE | ID: covidwho-1150277

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Hypertension Type of study: Diagnostic study / Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Hypertension Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Hypertension Type of study: Diagnostic study / Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Hypertension Year: 2021 Document Type: Article